ALK-1-negative anaplastic large cell lymphoma associated with breast implants: A new clinical entity

Clinical Breast Cancer

Volumn 11, Issue 5, 2011, Pages 283-296

  Lazzeri, Davide ^a,b   Agostini, Tommaso ^a   Bocci, Guido ^c   Giannotti, Giordano ^a   Fanelli, Giovanni ^c   Naccarato, Antonio Giuseppe ^c   Danesi, Romano ^c   Tuccori, Marco ^c   Pantaloni, Marcello ^a   D'Aniello, Carlo ^b  

^a Dept of Clin Microbiol Lab   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

^c UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Adverse effect; ALK 1 negative (ALK 1 ); Anaplastic large cell lymphoma; Breast implant; Cancer; Safety

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; ANAPLASTIC LYMPHOMA KINASE 1; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; PREDNISONE; SILICONE; UNCLASSIFIED DRUG; VINCRISTINE; PROTEIN TYROSINE KINASE; SILICONE DERIVATIVE; SODIUM CHLORIDE;

BREAST AUGMENTATION; BREAST ENDOPROSTHESIS; BREAST RECONSTRUCTION; BREAST TENDERNESS; BREAST TUMOR; CANCER COMBINATION CHEMOTHERAPY; CONTRACTURE; DEVICE REMOVAL; HISTOLOGY; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MASTALGIA; REVIEW; ADULT; AGED; CHEMICALLY INDUCED DISORDER; FEMALE; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BREAST IMPLANTS; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MIDDLE AGED; RECEPTOR PROTEIN-TYROSINE KINASES; RETROSPECTIVE STUDIES; SILICONES; SODIUM CHLORIDE;

EID: 81355165976     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2011.03.020     Document Type: Review

References (66)

1. Angell M. Shattuck lecture-evaluating the health risk of breast implants: the interplay of medical science, the law and public opinion. N Engl J Med 1996; 334: 1513-8. (Pubitemid 26166895)
2. Janowsky EC, Kupper LL, Hulka BS. Metaanalyses of the relation between silicone breast implants and the risk of connective tissue disease. N Engl J Med 2000; 342: 781-90. (Pubitemid 30151922)
3. Brinton LA, Brown SL. Breast implants and cancer. J Natl Cancer Inst 1997; 89: 1341-9. (Pubitemid 27418024)
4. Gabriel SE, Woods JE, O'Fallon WM, et al. Complications leading to surgery after breast implantation. N Engl J Med 1997; 336: 677-82. (Pubitemid 27102681)
5. Brinton LA. The relationship of silicone breast implants and cancer at other sites. Plast Reconstr Surg 2007; 120(suppl 1): 94S-102.
6. Lipworth L, Tarone RE, Friis S, et al. Cancer among Scandinavian women with cosmetic breast implants: a pooled long-term follow-up study. Int J Cancer 2008; 124: 490-3.
7. Deapen DM, Hirsch EM, Brody GS. Cancer risk among Los Angeles women with cosmetic breast implants. Plast Reconstr Surg 2007; 119: 1987-92. (Pubitemid 46847086)
8. Brisson J, Holowaty EJ, Villeneuve PJ, et al. Cancer incidence in a cohort of Ontario and Quebec women having bilateral breast augmentation. Int J Cancer 2006; 118: 2854-62. (Pubitemid 43673367)
9. Pukkala E, Boice JD Jr, Hovi SL, et al. Incidence of breast and other cancers among Finnish women with cosmetic breast implants, 1970-1999. J Long Term Eff Med Implants 2002; 12: 271-9. (Pubitemid 36232473)
10. Brinton LA, Lubin JH, Burich MC, et al. Cancer risk at sites other than the breast following augmentation mammoplasty. Ann Epidemiol 2001; 11: 248-56. (Pubitemid 32288854)
11. Brinton LA, Buckley LM, Dvorkina O, et al. Risk of connective tissue disorders among breast implant patients. Am J Epidemiol 2004; 160: 619-27. (Pubitemid 39281841)
12. de Jong D, Vasmel WL, de Boer JP, et al. Anaplastic large cell lymphoma in women with breast implants. JAMA 2008; 300: 2030-5.
13. Validire P, Capovilla M, Asselain B, et al. Primary breast non-Hodgkin's lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors. Am J Hematol 2009; 84: 133-9.
14. Talwalkar SS, Miranda RN, Valbuena JR, et al. Lymphomas involving the breast: a study of 106 cases comparing localized and disseminated neoplasms. Am J Surg Pathol 2008; 32: 1299-309.
15. Martinelli G, Ryan G, Seymour JF, et al. Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group. Ann Oncol 2009; 20: 1993-9.
16. Gualco G, Chioato L, Harrington WJ Jr, et al. Primary and secondary T-cell lymphomas of the breast: clinico-pathologic features of 11 cases. Appl Immunohistochem Mol Morphol 2009; 17: 301-6.
17. Jaffe ES, Harris NL, Stein H, et al, eds. Tumours of the Haematopoietic and Lymphoid Tissue. Lyon, France: IARC Press; 2001.
18. Lipworth L, Tarone RE, McLaughlin JK. Breast implants and lymphoma risk: a review of the epidemiologic evidence through 2008. Plast Reconstr Surg 2009; 123: 790-3.
19. Lechner MG, Lade S, Liebertz DJ, et al. Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity. Cancer 2011; 117: 1478-89.
20. Cook PD, Osborne BM, Connor RL, et al. Follicular lymphoma adjacent to foreign body granulomatous inflammation and fibrosis surrounding silicone breast prosthesis. Am J Surg Pathol 1995; 19: 712-7.
21. Duvic M, Moore D, Menter A, et al. Cutaneous T-cell lymphoma in association with silicone breast implants. J Am Acad Dermatol 1995; 32: 939-42.
22. Sendagorta E, Ledo A. Sézary syndrome in association with silicone breast implant. J Am Acad Dermatol 1995; 33: 1060-1.
23. Said JW, Tasaka T, Takeuchi S, et al. Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood 1996; 88: 3124-8. (Pubitemid 26357396)
24. Keech JA Jr, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg 1997; 100: 554-5.
25. Gaudet G, Friedberg JW, Weng A, et al. Breast lymphoma associated with breast implants: two case-reports and a review of the literature. Leuk Lymphoma 2002; 43: 115-9. (Pubitemid 34228827)
26. Sahoo S, Rosen PP, Feddersen RM, et al. Anaplastic large cell lymphoma arising in a silicone breast implant capsule: a case report and review of the literature. Arch Pathol Lab Med 2003; 127: e115-8.
27. Kraemer DM, Tony HP, Gattenlöhner S, et al. Lymphoplasmacytic lymphoma in a patient with leaking silicone implant. Haematologica 2004; 89: ELT01.
28. Fritzsche FR, Pahl S, Petersen I, et al. Anaplastic large-cell non-Hodgkin's lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer-a case report. Virchows Arch 2006; 449: 561-4. (Pubitemid 44722325)
29. Olack B, Gupta R, Brooks GS. Anaplastic large cell lymphoma arising in a saline breast implant capsule after tissue expander breast reconstruction. Ann Plast Surg 2007; 59: 56-7. (Pubitemid 46987980)
30. Roden AC, Macon WR, Keeney GL, et al. Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol 2008; 21: 455-63. (Pubitemid 351441035)
31. Newman MK, Zemmel NJ, Bandak AZ, et al. Primary breast lymphoma in a patient with silicone breast implants: a case report and review of the literature. J Plast Reconstr Aesthet Surg 2008; 61: 822-5. (Pubitemid 351970472)
32. Wong AK, Lopategui J, Clancy S, et al. Anaplastic large cell lymphoma associated with a breast implant capsule: a case report and review of the literature. Am J Surg Pathol 2008; 32: 1265-8.
33. Gualco G, Bacchi CE. B-cell and T-cell lymphomas of the breast: clinical-pathological features of 53 cases. Int J Surg Pathol 2008; 16: 407-13.
34. Farkash EA, Ferry JA, Harris NL, et al. Rare lymphoid malignancies of the breast: a report of two cases illustrating potential diagnostic pitfalls. J Hematop 2009; 2: 237-44.
35. Alobeid B, Sevilla DW, El-Tamer MB, et al. Aggressive presentation of breast implant-associated ALK-1 negative anaplastic large cell lymphoma with bilateral axillary lymph node involvement. Leuk Lymphoma 2009; 50: 831-3.
36. Bishara MR, Ross C, Sur M. Primary anaplastic large cell lymphoma of the breast arising in reconstruction mammoplasty capsule of saline filled breast implant after radical mastectomy for breast cancer: an unusual case presentation. Diagn Pathol 2009; 4: 11.
37. Miranda RN, Lin L, Talwalkar SS, et al. Anaplastic large cell lymphoma involving the breast: a clinicopathologic study of 6 cases and review of the literature. Arch Pathol Lab Med 2009; 133: 1383-90.
38. Li S, Lee AK. Silicone implant and primary breast ALK1-negative anaplastic large cell lymphoma, fact or fiction? Int J Clin Exp Pathol 2009; 3: 117-27.
39. Hanson SE, Gutowski KA. Primary T-cell lymphoma associated with breast implant capsule. Plast Reconstr Surg 2010; 126: 39e-41e.
40. Thompson PA, Lade S, Webster H, et al. Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity. Haematologica 2010; 95: 1977-9.
41. Do V, Shifrin DA, Oostendorp L. Lymphoma of the breast capsule in a silicone implant-reconstructed patient. Am Surg 2010; 76: 1030-1.
42. Lazzeri D, Giannotti G, Agostini T, et al. Null type ALK-negative anaplastic large cell lymphoma arising in a silicone breast implant capsule. A case report and review of the literature. Plast Reconstr Surg, in press.
43. Dusenbery D, Jones DB, Sapp KW, et al. Cytologic findings in the sarcomatoid variant of large cell anaplastic (Ki-1) lymphoma: a case report. Acta Cytol 1993; 37: 508-14. (Pubitemid 23214991)
44. Tan PH, Sng IT. Breast lymphoma-a pathologic study of 14 cases. Ann Acad Med Singapore 1996; 25: 783-90. (Pubitemid 126523259)
45. Lin Y, Govindan R, Hess JL. Malignant hematopoietic breast tumors. Am J Clin Pathol 1997; 107: 177-86. (Pubitemid 27098169)
46. Pillay P, Chetty R. Anaplastic large cell lymphoma of the breast. Int J Surg Pathol 1999; 7: 171-4. (Pubitemid 29360355)
47. Aguilera NS, Tavassoli FA, Chu WS, et al. T-cell lymphoma presenting in the breast: a histologic, immunophenotypic and molecular genetic study of four cases. Mod Pathol 2000; 13: 599-605. (Pubitemid 30436794)
48. Pereira EM, Maeda SA, Reis-Filho JS. Sarcomatoid variant of anaplastic large cell lymphoma mimicking a primary breast cancer. A challenging diagnosis. Arch Pathol Lab Med 2002; 126: 723-6. (Pubitemid 34602578)
49. Iyengar P, Reid-Nicholson M, Moreira AL. Pregnancy-associated anaplastic largecell lymphoma of the breast: a rare mimic of ductal carcinoma. Diagn Cytopathol 2006; 34: 298-302.
50. Medeiros LJ, Elenitoba-Johnson KS. Anaplastic large cell lymphoma. Am J Clin Pathol 2007; 127: 707-22.
51. Guo HY, Zhao XM, Li J, et al. Primary non-Hodgkin's lymphoma of the breast: eight-year follow-up experience. Int J Hematol 2008; 87: 491-7.
52. Kelten C, Kabukcu S, Sen N, et al. Secondary involvement of the breast in T-cell non-Hodgkin lymphoma, an unusual example mimicking inflammatory breast carcinoma. Arch Gynecol Obstet 2009; 280: 149-52.
53. Krishnan C, Moline S, Anders K, et al. Intravascular ALK positive anaplastic large cell lymphoma mimicking inflammatory breast carcinoma. J Clin Oncol 2009; 27: 2563-5.
54. Daneshbod Y, Oryan A, Khojasteh HN, et al. Primary ALK-positive anaplastic large cell lymphoma of the breast: a case report and review of the literature. J Pediatr Hematol Oncol 2010; 32: e75-8.
55. Querfeld C, Khan I, Mahon B, et al. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options. Oncology 2010; 24: 574-87.
56. Delsol G, Ralfkiaer E, Stein H, et al. Anaplastic large cell lymphoma. In: Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001: 230-5.
57. Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848-58. (Pubitemid 15242469)
58. ten Berge RL, Oudejans JJ, Ossenkoppele GJ, et al. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination. J Clin Pathol 2000; 53: 445-50. (Pubitemid 30396466)
59. Gascoyne RD, Aoun P, Wu D, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 1999; 93: 3913-21. (Pubitemid 29249840)
60. Rosen PP. Lymphoid and hematopoietic tumors. In: Rosen's Breast Pathology. New York, NY Lippincott-Raven; 1997: 757-78.
61. Bonzheim I, Geissinger E, Roth S, et al. Anaplastic large cell lymphoma lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling. Blood 2004; 104: 3358-60. (Pubitemid 39507158)
62. Shanklin DR, Smalley DL. The immune pathology of siliconosis. Immunol Res 1998; 18: 125-173.
63. van Diest PJ, Beekman WH, Hage JJ. Pathology of silicone leakage from breast implants. J Clin Pathol 1998; 51: 493-7. (Pubitemid 28375026)
64. Jacobsen E. Anaplastic large-cell lymphoma, T-/null-cell type. Oncologist 2006; 11: 831-40. (Pubitemid 44157571)
65. Kaufmann TP, Coleman M, Nisce LZ. Ki-1 skin lymphoproliferative disorders: management with radiation therapy. Cancer Invest 1997; 15: 91-7.
66. Vonderheid EC, Sajjadian A, Kadin ME. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders. J Am Acad Dermatol 1996; 34: 470-81. (Pubitemid 26083827)